JAZZ - Jazz Pharmaceuticals Non-GAAP EPS of $4.84 misses by $0.09 revenue of $972.14M beats by $2.8M
2023-11-08 16:12:15 ET
More on Jazz Pharmaceuticals
- Jazz Pharma: Playing The High Notes With Xywav
- Jazz Pharmaceuticals Q3 2023 Earnings Preview
- Jazz Pharmaceuticals Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Jazz Pharmaceuticals
- Historical earnings data for Jazz Pharmaceuticals
For further details see:
Jazz Pharmaceuticals Non-GAAP EPS of $4.84 misses by $0.09, revenue of $972.14M beats by $2.8M